Home / Publication / Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action

論文

Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action

Author(s): Jinshan Shen PhD, Kenneth T. Moore MA, MS, FAHA, Suneet Shukla PhD, Karen Rowland Yeo PhD, Karthik Venkatakrishnan PhD, FCP, the ACCP Public Policy Committee

Year: 2023年10月27日

サターラ、2024年の研究成果を発表 ―100本超の論文を公開

プレスリリース

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

お知らせ

Automated Writing Without the Compromise

製品紹介資料

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

ポスター

Powered by Translations.com GlobalLink Web Software

Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action

Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action

サターラ、2024年の研究成果を発表 ―100本超の論文を公開

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

Automated Writing Without the Compromise

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

メルマガ登録

クイックアクセス

ソリューション

お問合せ